Navigation Links
Microfabrica Introduces Set of Miniature 'Building Blocks' for Minimally-Invasive Medical Devices
Date:12/18/2007

1-mm turbine, miniaturized 'car jack', and micro-chainmail demonstrate the

company's ultra-precision EFAB manufacturing technology

VAN NUYS, Calif., Dec. 18 /PRNewswire/ -- Microfabrica Inc. will introduce at Medical Design & Manufacturing West a set of highly-miniaturized 'building blocks' which designers of minimally-invasive medical devices can use to develop innovative new products. Water-powered turbines just over 1 mm in diameter which spin at 120,000 revolutions per minute, millimeter-scale 'car jack'-like expanders, ultra-flexible micro-chainmail metal fabric, micro- needles, miniature ratchets, hinges, slides, and springs, and multi-lumen metal shapes are among the building blocks to be featured. Enabled by the company's unique EFAB manufacturing technology, these building blocks -- and devices based on them -- will be on display in Booth 466, Hall E, Anaheim Convention Center, Anaheim, CA, January 29-31, 2008.

According to Microfabrica chief executive officer Vacit Arat, "EFAB has already been used successfully in a variety of non-medical applications, and the technology's reliability and design flexibility have been put to test. Leveraging that experience, Microfabrica introduced the technology to select medical device companies in the last 12 months, and the response has been overwhelming. Several major players have already taken advantage of the technology to enable next-generation devices and dramatically cut cost." Beginning with MD&M, Microfabrica will make its technology broadly available to medical device manufacturers. The company's building blocks are meant to demonstrate what is possible and give engineers a head start on leveraging EFAB in their designs.

"The micro-turbine -- probably the world's smallest -- might be used as a high-speed distal actuator in thrombectomy, atherectomy, and intravascular ultrasound catheters, eliminating the need for a drive cable," noted Adam Cohen, chief technology officer of Microfabrica. "The expander can anchor and manipulate a catheter or retract tissue, while chainmail-based fabric is well- suited for distal protection or retrieval, especially in tortuous vessels, due to its unusual flexibility. Meanwhile, robust, hollow microneedles can enable intradermal and precision drug delivery systems."

EFAB technology differs from conventional manufacturing processes in several ways. By applying to mechanical device fabrication the techniques used to make computer chips, EFAB provides an accuracy and repeatability on the order of 0.001 mm, as well as direct scalability from prototype to volume production. The technology also offers an unprecedented new capability: it can directly produce assemblies such as mechanisms with dozens of moving parts, without the need for assembly. Compared with machining, metal injection molding, and electrical discharge machining, EFAB offers greater complexity, smaller features, and often greater accuracy and lower cost. Compared with laser or photochemical machining and stamping, EFAB offers greater accuracy, smaller features, and freedom from artifacts. The technology is mature, well- characterized, and extremely versatile. Products for specialties such as interventional cardiology and neurointerventional radiology, endoscopy, head, neck and neurosurgery, drug delivery, gastroenterology, urology, cardiac rhythm management, cardiac and vascular surgery, ophthalmology, and cosmetic surgery are under discussion or in commercial development.

About Microfabrica

Microfabrica Inc. (http://www.microfabrica.com) is a leading manufacturer of micro and millimeter-scale mechanical devices used in a variety of medical, electronics and defense applications. The company's unique EFAB technology offers an unprecedented capability to cost-effectively, flexibly manufacture highly-miniaturized components and mechanisms in production volumes. EFAB is the only manufacturing technology to produce robust, fully-assembled devices millimeters to centimeters in size with micron-scale features. EFAB technology opens up a world of possibilities for sophisticated, miniaturized devices otherwise impossible or impractical to produce.

Contact:

Irene Ajemyan

(818) 786-3322 Ext. 150

Photos available upon request:

Turbine built using Microfabrica's EFAB(r) technology.

Four-direction car jack-like 'expander' next to a penny.

Ultra-flexible metal mesh basket approximately 2 mm wide.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Microfabrica Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
5. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
6. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Norwood, MA (PRWEB) , ... February 28, 2017 ... ... successful clinical trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial ... is celebrating 15 years of meeting this unique need within the biotechnology and ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ., a ... repertoires, today announced a strategic partnership with Trianni, Inc. , a biotechnology ... antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody therapeutics through ...
(Date:2/28/2017)... 28, 2017 Sangamo Therapeutics, Inc. (NASDAQ: ... reported its fourth quarter and full year 2016 ... this year we rebranded our company as Sangamo ... genomic therapies using our industry leading platform technologies ... cell therapy," said Sandy Macrae , CEO ...
(Date:2/27/2017)... VANCOUVER , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, ... to their expiry on Friday, February 24, 2017 a total ... a price of $0.13 per common share. Proceeds from the ... were issued from InMed,s Treasury.   ... "We are grateful for this expression ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):